FlowSense develops a patented, non-invasive device that detects period blood and tracks menstrual cycles for users. This technology specifically addresses accessibility challenges faced by visually impaired women regarding menstrual health management. The product integrates cycle tracking with essential menstrual health education.
Funding
$20K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Visually impaired women face challenges in independently managing their menstrual hygiene, leading to potential health risks associated with pad overuse, such as infections and toxic shock syndrome. The lack of a reliable method for detecting menstrual blood can also hinder accurate cycle tracking.
Solution
FlowSense offers a non-invasive device designed to detect menstrual blood, enabling visually impaired women to manage their menstrual hygiene with greater independence. The device aims to reduce the health risks associated with prolonged pad use by providing timely alerts. By facilitating independent detection, FlowSense also empowers users to track their cycles more effectively and make informed decisions about their menstrual health.
Target Audience
The primary target audience is visually impaired women who require a reliable and independent method for managing their menstrual hygiene.
Features
- Non-invasive detection of menstrual blood
- Discreet and portable design for ease of use
- Aims to reduce health risks associated with pad overuse
- Facilitates independent menstrual hygiene management
- Supports accurate cycle tracking